CoChat

MiR-133b targets Sox9 to control pathogenesis and metastasis of breast cancer

Wang, Qiu-Yu, Zhou, Ci-Xiang, Zhan, Meng-Na, Tang, Jun, Wang, Chen-Long, Ma, Cheng-Ning, He, Ming, Chen, Guo-Qiang, He, Jian-Rong, Zhao, Qian · 2018 · Cell Death & Disease
Cited by 55

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

The miR-133b, a commonly recognized muscle-specific miRNA, was reported to be deregulated in many kinds of cancers. However, its potential roles in tumorigenesis remain greatly elusive. Herein, we demonstrate that miR-133b is significantly suppressed in human breast cancer specimens, which is reversely correlated to histological grade of the cancer. Ectopic expression of miR-133b suppresses clonogenic ability and metastasis-relevant traits in vitro, as well as carcinogenesis and pulmonary metastasis in vivo. Further studies have identified Sox9, c-MET, and WAVE2 as direct targets of miR-133b, in which Sox9 contributes to all miR-133b-endowed effects including cell proliferation, colony formation, as well as cell migration and invasion in vitro. Moreover, re-expression of Sox9 reverses miR-133b-mediated metastasis suppression in vivo. Taken together, these findings highlight an important role for miR-133b in the regulation of tumorigenesis and metastatic potential of breast cancer and suggest a potential application of miR-133b in cancer treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41419-018-0715-6

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 39

  1. Cancer Genome, Atlas, N. Comprehensive molecular portraits of human breast tumours. Nature 490, 61–70 (2012). · DOI · Paper page
  2. Gupta, G. P. & Massague, J. Cancer metastasis: building a framework. Cell 127, 679–695 (2006). · DOI · Paper page
  3. Fidler, I. J. Timeline - the pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nat. Rev. Cancer 3, 453–458 (2003). · DOI · Paper page
  4. Valastyan, S. & Weinberg, R. A. Tumor metastasis: molecular insights and evolving paradigms. Cell 147, 275–292 (2011). · DOI · Paper page
  5. Charafe-Jauffret, E. et al. Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res. 69, 1302–1313 (2009). · DOI · Paper page
  6. Pang, R. et al. A subpopulation of CD26(+) cancer stem cells with metastatic capacity in human colorectal cancer. Cell. Stem. Cell. 6, 603–615 (2010). · DOI · Paper page
  7. Hermann, P. C. et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell. Stem. Cell. 1, 313–323 (2007). · DOI · Paper page
  8. Nguyen, D. X., Bos, P. D. & Massague, J. Metastasis: from dissemination to organ-specific colonization. Nat. Rev. Cancer 9, 274–U265 (2009). · DOI · Paper page
  9. Chaffer, C. L. & Weinberg, R. A. A perspective on cancer cell metastasis. Science 331, 1559–1564 (2011). · DOI · Paper page
  10. Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281–297 (2004). · DOI
  11. Bartel, D. P. MicroRNAs: target recognition and regulatory functions. Cell 136, 215–233 (2009). · DOI · Paper page
  12. Alvarez-Garcia, I. & Miska, E. A. MicroRNA functions in animal development and human disease. Development 132, 4653–4662 (2005). · DOI · Paper page
  13. Calin, G. A. & Croce, C. M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 6, 857–866 (2006). · DOI · Paper page
  14. Shimono, Y. et al. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 138, 592–603 (2009). · DOI · Paper page
  15. Ma, L. et al. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat. Cell Biol. 12, 247–256 (2010). · DOI · Paper page
  16. Valastyan, S. et al. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 137, 1032–1046 (2009). · DOI · Paper page
  17. Ryu, S. et al. Suppression of miRNA-708 by polycomb group promotes metastases by calcium-induced cell migration. Cancer Cell. 23, 63–76 (2013). · DOI
  18. Rao, P. K., Kumar, R. M., Farkhondeh, M., Baskerville, S. & Lodish, H. F. Myogenic factors that regulate expression of muscle-specific microRNAs. Proc. Natl Acad. Sci. USA 103, 8721–8726 (2006). · DOI · Paper page
  19. Xiao, L. et al. Feedback remodeling of cardiac potassium current expression: a novel potential mechanism for control of repolarization reserve. Circulation 118, 983–992 (2008). · DOI
  20. Townley-Tilson, W. H., Callis, T. E. & Wang, D. MicroRNAs 1, 133, and 206: critical factors of skeletal and cardiac muscle development, function, and disease. Int. J. Biochem. Cell. Biol. 42, 1252–1255 (2010). · DOI · Paper page
  21. Sanchez-Simon, F. M., Zhang, X. X., Loh, H. H., Law, P. Y. & Rodriguez, R. E. Morphine regulates dopaminergic neuron differentiation via miR-133b. Mol. Pharmacol. 78, 935–942 (2010). · DOI
  22. Trajkovski, M., Ahmed, K., Esau, C. C. & Stoffel, M. MyomiR-133 regulates brown fat differentiation through Prdm16. Nat. Cell Biol. 14, 1330–1335 (2012). · DOI · Paper page
  23. Nohata, N., Hanazawa, T., Enokida, H. & Seki, N. microRNA-1/133a and microRNA-206/133b clusters: dysregulation and functional roles in human cancers. Oncotarget 3, 9–21 (2012). · DOI · Paper page
  24. Hu, G. et al. miR-133b regulates the MET proto-oncogene and inhibits the growth of colorectal cancer cells in vitro and in vivo. Cancer Biol. Ther. 10, 190–197 (2010). · DOI
  25. Wen, D. et al. miR-133b acts as a tumor suppressor and negatively regulates FGFR1 in gastric cancer. Tumour Biol. 34, 793–803 (2013). · DOI
  26. Crawford, M. et al. MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer. Biochem. Biophys. Res. Commun. 388, 483–489 (2009). · DOI · Paper page
  27. Kano, M. et al. miR-145, miR-133a and miR-133b: tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int. J. Cancer 127, 2804–2814 (2010). · DOI · Paper page
  28. Nicoloso, M. S., Spizzo, R., Shimizu, M., Rossi, S. & Calin, G. A. MicroRNAs--the micro steering wheel of tumour metastases. Nat. Rev. Cancer 9, 293–302 (2009). · DOI · Paper page
  29. Qin, W. et al. MicroRNA-133b is a key promoter of cervical carcinoma development through the activation of the ERK and AKT1 pathways. Oncogene 31, 4067–4075 (2012). · DOI
  30. Lanczky, A. et al. miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients. Breast Cancer Res. Treat. 160, 439–446 (2016). · DOI · Paper page
  31. Ventura, A. & Jacks, T. MicroRNAs and cancer: short RNAs go a long way. Cell 136, 586–591 (2009). · DOI · Paper page
  32. Chaboissier, M. C. et al. Functional analysis of Sox8 and Sox9 during sex determination in the mouse. Development 131, 1891–1901 (2004). · DOI · Paper page
  33. Grimont, A. et al. SOX9 regulates ERBB signalling in pancreatic cancer development. Gut 64, 1790–1799 (2015). · DOI · Paper page
  34. Kordes, U. & Hagel, C. Expression of SOX9 and SOX10 in central neuroepithelial tumor. J. Neurooncol. 80, 151–155 (2006). · DOI
  35. Perou, C. M. et al. Molecular portraits of human breast tumours. Nature 406, 747–752 (2000). · DOI · Paper page
  36. Guo, W. et al. Slug and Sox9 cooperatively determine the mammary stem cell state. Cell 148, 1015–1028 (2012). · DOI · Paper page
  37. Kurisu, S., Suetsugu, S., Yamazaki, D., Yamaguchi, H. & Takenawa, T. Rac-WAVE2 signaling is involved in the invasive and metastatic phenotypes of murine melanoma cells. Oncogene 24, 1309–1319 (2005). · DOI
  38. Wang, J. et al. SH3BP1-induced Rac-Wave2 pathway activation regulates cervical cancer cell migration, invasion, and chemoresistance to cisplatin. J. Cell. Biochem. 119, 1733–1745 (2018). · DOI
  39. Semba, S. et al. Coexpression of actin-related protein 2 and Wiskott-Aldrich syndrome family verproline-homologous protein 2 in adenocarcinoma of the lung. Clin. Cancer Res. 12, 2449–2454 (2006). · DOI · Paper page

Cited by

See all 55

Metadata

Authors
Wang, Q.-Y., Zhou, C.-X., Zhan, M.-N., Tang, J., Wang, C.-L., Ma, C.-N., He, M., Chen, G.-Q., He, J.-R., & Zhao, Q.
Venue
Cell Death & Disease
Published
2018-07-03
Volume
9
Issue
7
ISSN
2041-4889
Cited by
55
References
7
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: MiR-133b targets Sox9 to control pathogenesis and metastasis of breast cancer. https://app.cochat.ai/papers/10.1038/s41419-018-0715-6
The paper
Wang, Q.-Y., Zhou, C.-X., Zhan, M.-N., Tang, J., Wang, C.-L., Ma, C.-N., He, M., Chen, G.-Q., He, J.-R., & Zhao, Q. (2018). MiR-133b targets Sox9 to control pathogenesis and metastasis of breast cancer. Cell Death & Disease. https://doi.org/10.1038/s41419-018-0715-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.